The Rise of Life Sciences: Navigating Complex Real Estate Secondaries in India

Real Estate Secondaries in India: Life Sciences Parks as Institutional Assets

The global pandemic accelerated many structural shifts in real estate, but few have been as pronounced as the institutionalisation of life sciences property. Research parks, pharmaceutical manufacturing campuses, and biotech clusters have moved from niche to mainstream in the space of two years. In India, where the pharmaceutical sector is a global powerhouse, this shift has created a compelling opportunity for sophisticated secondary investors.

The MN Parks Transaction: A Case Study in Cross-Border Real Estate Secondaries

The transaction saw Ivanhoe Cambridge, the real estate arm of CDPQ, partner with Lighthouse Canton to invest in a 0.8 million square foot life sciences park — MN Parks — in Hyderabad. The deal was structured as a GP-led secondary, allowing the original developer to recycle capital into new projects while bringing in long term institutional capital to manage the stabilised asset. Lensbridge Capital served as the independent financial advisor, providing valuation analysis and managing the transaction process from mandate to close.

Independent Advisory in Complex Indian Real Estate Transactions

For Lensbridge, the MN Parks mandate was a testament to our ability to handle high stakes, cross border advisory work. The transaction required navigating the regulatory nuances of Indian real estate, the specific requirements of a Canadian pension fund, and the valuation methodology appropriate for a specialised asset class. The successful close was a validation of our approach: deep sector knowledge, rigorous process, and an unwavering focus on the interests of our client.

The Future of Indian Real Estate Secondaries: Logistics, Data Centres, and Life Sciences

As we look ahead, the success of the MN Parks deal provides a blueprint for future GP-led secondaries in the region. The Indian real estate market is maturing rapidly, and the pipeline of institutionally managed assets — from logistics parks to data centres to life sciences campuses — is growing. For secondary investors with the patience and expertise to navigate the complexity, the opportunity is substantial. We expect to see a significant increase in the volume and sophistication of these transactions over the next three to five years.